Landec Corp expected to post breakeven results a share - Earnings Preview

Lifecore Biomedical

01/04/2022 21:23

* Landec Corp  LNDC.OQ   LNDC.O  is expected to show a fall
in
quarterly revenue when it reports  results on April 5. 
    * The Santa Maria California-based  company is expected to
report 
a 64.9% decrease in revenue to $48.414 million from $137.78
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Landec Corp is for
breakeven results per share. For the same quarter last year, the
company reported a loss of 9 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Landec Corp
is
$14​, above​ its last closing price of $11.58. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Nov. 30 2021  -0.04       -0.04      0.05      Beat    225
 Aug. 31 2021  -0.12       -0.12      -0.23     Missed  -98.3
 May. 31 2021  -0.01       -0.01      0.07      Beat    975​
 Feb. 28 2021  0.03        0.02       -0.09     Missed  -475
 ​​Nov.        0.03        0.01       0.02      Beat    100
 30 2020                                                
 Aug. 31 2020  -0.12       -0.11      -0.11     Met     0​
 May. 31 2020  0.03        0.03       0.05      Beat    81.8
 Feb. 29 2020  0.02        0.03       0.04      Beat    60
 This summary was machine generated April 1 at 20:23 GMT.  All
figures in US dollars  unless otherwise stated